🇺🇸 Fluticasone/Salmeterol HFA in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Dyspnoea — 2 reports (18.18%)
2. Angina Unstable — 1 report (9.09%)
3. Chest Discomfort — 1 report (9.09%)
4. Clostridium Test Positive — 1 report (9.09%)
5. Colitis — 1 report (9.09%)
6. Crohn^S Disease — 1 report (9.09%)
7. Cystitis — 1 report (9.09%)
8. Cytomegalovirus Test Positive — 1 report (9.09%)
9. Fatigue — 1 report (9.09%)
10. Heart Rate Increased — 1 report (9.09%)

Source database →

Frequently asked questions

Is Fluticasone/Salmeterol HFA approved in United States?

Fluticasone/Salmeterol HFA does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Fluticasone/Salmeterol HFA in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.